Wiener Klinische Wochenschrift最新文献

筛选
英文 中文
BillrothhausTV: Fortbildung, wann und wo Sie wollen. 《时间与地点》。
IF 2.6 4区 医学
Wiener Klinische Wochenschrift Pub Date : 2026-10-01 DOI: 10.1007/s00508-026-02848-z
{"title":"BillrothhausTV: Fortbildung, wann und wo Sie wollen.","authors":"","doi":"10.1007/s00508-026-02848-z","DOIUrl":"https://doi.org/10.1007/s00508-026-02848-z","url":null,"abstract":"","PeriodicalId":23861,"journal":{"name":"Wiener Klinische Wochenschrift","volume":"138 19-20","pages":"650"},"PeriodicalIF":2.6,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149196901","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A rare case of nephrotic syndrome and arterial thrombosis following long-term rifampicin therapy. 长期利福平治疗后并发肾病综合征及动脉血栓的罕见病例。
IF 2.6 4区 医学
Wiener Klinische Wochenschrift Pub Date : 2026-10-01 Epub Date: 2026-03-27 DOI: 10.1007/s00508-026-02736-6
Satish Kumar Basattikoppalu Puttegowda, Pooja Anjanappa, Tejaswi Prithviraj Hadya Krishna, Yogendra Shrestha
{"title":"A rare case of nephrotic syndrome and arterial thrombosis following long-term rifampicin therapy.","authors":"Satish Kumar Basattikoppalu Puttegowda, Pooja Anjanappa, Tejaswi Prithviraj Hadya Krishna, Yogendra Shrestha","doi":"10.1007/s00508-026-02736-6","DOIUrl":"10.1007/s00508-026-02736-6","url":null,"abstract":"<p><p>Although rifampicin is one of the main drugs in the treatment of tuberculosis, its potential for causing nephrotoxic reactions may lead to renal injury. In this paper, we present a 23-year-old man who was treated for pulmonary tuberculosis and who developed a nephrotoxic syndrome caused by rifampicin. This syndrome was defined by abdominal distension due to fluid retention, swelling in both legs, nephrotic range proteinuria and biopsy findings showing tubular atrophy and interstitial fibrosis. The nephrotoxicity developed after a prolonged, uninterrupted course of treatment with rifampicin. The patient was successfully treated for nephrotoxicity with corticosteroids, diuretics, albumin infusion and antihypertensive agents. We emphasize the need for clinicians to be aware of the risk of rifampicin nephrotoxicity, particularly in patients with pre-existing renal impairment.</p>","PeriodicalId":23861,"journal":{"name":"Wiener Klinische Wochenschrift","volume":" ","pages":"638-641"},"PeriodicalIF":2.6,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147533309","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Austrian treatment algorithms 2025: CDK 4/6 inhibitors in the adjuvant therapy of HR+/HER2- early breast cancer. 奥地利治疗算法2025:cdk4 /6抑制剂辅助治疗HR+/HER2-早期乳腺癌。
IF 2.6 4区 医学
Wiener Klinische Wochenschrift Pub Date : 2026-10-01 Epub Date: 2026-03-18 DOI: 10.1007/s00508-026-02726-8
Rupert Bartsch, Clemens Dormann, Daniel Egle, Simon P Gampenrieder, Gunda Pristauz-Telsnigg, Gabriel Rinnerthaler, Christian F Singer, Michael Gnant
{"title":"Austrian treatment algorithms 2025: CDK 4/6 inhibitors in the adjuvant therapy of HR+/HER2- early breast cancer.","authors":"Rupert Bartsch, Clemens Dormann, Daniel Egle, Simon P Gampenrieder, Gunda Pristauz-Telsnigg, Gabriel Rinnerthaler, Christian F Singer, Michael Gnant","doi":"10.1007/s00508-026-02726-8","DOIUrl":"10.1007/s00508-026-02726-8","url":null,"abstract":"<p><p>Hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) early breast cancer (eBC) represents the most common breast cancer subtype, with relevant recurrence risks despite optimal endocrine therapy (ET) and locoregional treatment. Long-term data from the Early Breast Cancer Trialists' Collaborative Group (EBCTCG) demonstrate that recurrence risk remains substantial, with outcomes strongly influenced by nodal burden, tumor size, and biological parameters.Advances in systemic therapy, including optimized endocrine strategies, chemotherapy, bone-modifying agents, PARP inhibitors for patients harboring germline BRCA 1/2-mutations, have significantly improved survival, yet recurrence remains a clinically relevant challenge, including for node-negative patients harboring additional biological risk features.The introduction of adjuvant CDK4/6 inhibitors represents an important therapeutic development. Abemaciclib (monarchE) has demonstrated sustained improvements in invasive disease-free survival (IDFS), distant relapse-free survival (DRFS), and a statistically significant overall survival (OS) benefit at 7 years. Ribociclib (NATALEE) demonstrated statistically significant IDFS improvement across a broader clinical risk spectrum, including selected node-negative disease.However, these advances must be considered in the context of distinct toxicity, treatment burden, and substantial additional healthcare system costs. Although emerging evidence supports treatment intensification with CDK4/6 inhibitors in certain settings, uncertainty persists regarding which patient subgroups derive sufficient benefit to justify routine use from both a clinical and health-economic perspective.Further clarification is expected from ongoing randomized studies and real-world evidence, as this paper aims to provide a structured, evidence-based overview of the current standard of knowledge and to support Austrian breast cancer specialists in navigating treatment decisions regarding adjuvant CDK4/6 inhibitor use.</p>","PeriodicalId":23861,"journal":{"name":"Wiener Klinische Wochenschrift","volume":" ","pages":"599-611"},"PeriodicalIF":2.6,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13672391/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147481956","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
It's not always endocarditis: splinter hemorrhages in ANCA-associated vasculitis. 它并不总是心内膜炎:anca相关血管炎的碎片出血。
IF 2.6 4区 医学
Wiener Klinische Wochenschrift Pub Date : 2026-10-01 Epub Date: 2026-03-19 DOI: 10.1007/s00508-026-02734-8
Werner Ribitsch, Alexandra Radler
{"title":"It's not always endocarditis: splinter hemorrhages in ANCA-associated vasculitis.","authors":"Werner Ribitsch, Alexandra Radler","doi":"10.1007/s00508-026-02734-8","DOIUrl":"10.1007/s00508-026-02734-8","url":null,"abstract":"","PeriodicalId":23861,"journal":{"name":"Wiener Klinische Wochenschrift","volume":" ","pages":"645-646"},"PeriodicalIF":2.6,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13672514/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147487479","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An analysis of COVID-19 mortality regarding all Austrian political districts. 奥地利所有政治选区COVID-19死亡率分析。
IF 2.6 4区 医学
Wiener Klinische Wochenschrift Pub Date : 2026-10-01 Epub Date: 2026-03-26 DOI: 10.1007/s00508-026-02728-6
Stefanie Grötz, Martin Fieder, Harald Wilfing
{"title":"An analysis of COVID-19 mortality regarding all Austrian political districts.","authors":"Stefanie Grötz, Martin Fieder, Harald Wilfing","doi":"10.1007/s00508-026-02728-6","DOIUrl":"10.1007/s00508-026-02728-6","url":null,"abstract":"<p><strong>Background: </strong>Coronavirus disease 2019 (COVID-19), first identified in Wuhan in 2019, rapidly escalated into a global pandemic. Austria reported its initial cases in February 2020, resulting in millions of infections and thousands of deaths. This study investigates COVID-19 mortality across Austrian districts, analyzing factors such as age, sex, immigrant background, household size, education and vaccination status.</p><p><strong>Methods: </strong>We analyzed data from the Austrian National Public Health Institute, comprising 4,591,739 confirmed cases and 20,123 deaths as of July 2022. We used a linear mixed model to examine whether individuals died from COVID-19. Furthermore, we created three interaction models: (i) vaccination status and consecutive month, (ii) age and consecutive month and (iii) sex and consecutive month. Additional linear models examined household size, education, and citizenship at the district level.</p><p><strong>Results: </strong>Our findings highlight several determinants of COVID-19 mortality in Austria. Advanced age significantly increases mortality risk, while vaccination is strongly protective. Female sex is also associated with reduced mortality. District of residence influences the case fatality ratio, with notable geographic variation. Larger household sizes correlate with increased infection risk. Districts with higher proportions of residents with tertiary education exhibit lower infection and mortality ratio. Districts with a greater percentage of non-Austrian citizens have lower case fatality ratio, likely reflecting a younger population demography.</p><p><strong>Conclusion: </strong>Key determinants of COVID-19 mortality include age, vaccination status, and sex. Districts with larger households experience higher infection ratios, while those with more highly educated residents have lower infection and mortality ratios. Districts with more non-Austrian citizens show lower case fatality ratios, likely due to younger populations. Further research into district-level age structures is warranted to refine these models. These findings underscore the importance of vaccination, particularly among older adults, and the need for accessible public health education to reduce infection and mortality ratio, especially in less-educated populations; however, district age structure (proportion of older individuals) substantially influences these associations.</p>","PeriodicalId":23861,"journal":{"name":"Wiener Klinische Wochenschrift","volume":" ","pages":"585-598"},"PeriodicalIF":2.6,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13672430/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147515091","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Systematic evidence analysis of symptom modification in hip osteoarthritis following MSC-based interventions. 基于msc的干预对髋关节骨关节炎症状改善的系统证据分析。
IF 2.6 4区 医学
Wiener Klinische Wochenschrift Pub Date : 2026-09-28 DOI: 10.1007/s00508-026-02820-x
Paul Steiner, Theodor Seist, Lukas Moser, Johannes Neugebauer, Dietmar Dammerer, Stefan Nehrer, Markus Neubauer
{"title":"Systematic evidence analysis of symptom modification in hip osteoarthritis following MSC-based interventions.","authors":"Paul Steiner, Theodor Seist, Lukas Moser, Johannes Neugebauer, Dietmar Dammerer, Stefan Nehrer, Markus Neubauer","doi":"10.1007/s00508-026-02820-x","DOIUrl":"https://doi.org/10.1007/s00508-026-02820-x","url":null,"abstract":"<p><strong>Background: </strong>Mesenchymal stromal/stem cell (MSC)-based interventions are increasingly used for hip osteoarthritis (HOA), although the products and supporting clinical evidence are heterogeneous. This systematic review evaluated symptom modification, safety, and methodological quality.</p><p><strong>Methods: </strong>PubMed/MEDLINE was searched on 1 August 2024 using MeSH and free-text terms. One author performed study screening, data extraction, and risk of bias assessment using the Downs and Black checklist and 9 studies comprising 307 patients were included. Because of clinical and methodological heterogeneity, results were synthesized descriptively; weighted outcome means were calculated only from studies reporting compatible baseline and follow-up values.</p><p><strong>Results: </strong>The interventions included culture-expanded MSCs, bone marrow concentrate, stromal vascular fraction, and micro-fragmented adipose tissue, with or without platelet-rich plasma. In contributing cohorts, VAS pain scores decreased from 6.7 to 3.7 (n = 58), WOMAC scores decreased from 35.4 to 18.5 (n = 49), and Harris hip scores increased from 40.8 to 62.8 (n = 76). These findings represent within-group changes rather than comparative treatment effects. Serious adverse events were uncommon, but reporting was incomplete and follow-up was generally limited.</p><p><strong>Conclusion: </strong>The use of MSC-based interventions was associated with encouraging short-term within-group improvements in pain and function; however, small samples, product heterogeneity, predominantly uncontrolled designs and limited safety reporting preclude conclusions regarding efficacy or structural disease modification. Adequately powered randomized controlled trials with standardized products and outcomes are required.</p>","PeriodicalId":23861,"journal":{"name":"Wiener Klinische Wochenschrift","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149075429","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sudden cardiac arrest in a young healthy man following kratom tea consumption: a case report and brief literature review. 年轻健康男性饮用克拉通茶后心脏骤停一例报告及简要文献回顾。
IF 2.6 4区 医学
Wiener Klinische Wochenschrift Pub Date : 2026-09-23 DOI: 10.1007/s00508-026-02826-5
Jonas Dunz, Mirco Janes, Armin Krösbacher, Regina Unterpertinger, Gabriel Putzer
{"title":"Sudden cardiac arrest in a young healthy man following kratom tea consumption: a case report and brief literature review.","authors":"Jonas Dunz, Mirco Janes, Armin Krösbacher, Regina Unterpertinger, Gabriel Putzer","doi":"10.1007/s00508-026-02826-5","DOIUrl":"https://doi.org/10.1007/s00508-026-02826-5","url":null,"abstract":"<p><p>We report the first case in Austria of cardiac arrest associated with isolated kratom intoxication in a young man, supported by toxicological blood analysis revealing markedly elevated mitragynine concentrations. Despite its perception as a low-risk substance, kratom can cause severe and potentially fatal adverse effects. This case highlights the need for increased clinical awareness, public education and further investigation of the cardiovascular safety of mitragynine.</p>","PeriodicalId":23861,"journal":{"name":"Wiener Klinische Wochenschrift","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149031557","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tumor-induced osteomalacia caused by fibroblast growth factor 23 excess : Delayed diagnosis resulting from overlooked hypophosphatemia-A  case report. 由成纤维细胞生长因子23过量引起的肿瘤性骨软化:因被忽视的低磷血症而延误诊断- 1例报告。
IF 2.6 4区 医学
Wiener Klinische Wochenschrift Pub Date : 2026-09-22 DOI: 10.1007/s00508-026-02821-w
Seren Aksun, Nergis Basmaci, Mehmet Ayvaz, Deniz Pınar Baran, Kemal Kosemehmetoglu, Yahya Eryılmaz, Eser Lay Ergün, Alper Gürlek
{"title":"Tumor-induced osteomalacia caused by fibroblast growth factor 23 excess : Delayed diagnosis resulting from overlooked hypophosphatemia-A  case report.","authors":"Seren Aksun, Nergis Basmaci, Mehmet Ayvaz, Deniz Pınar Baran, Kemal Kosemehmetoglu, Yahya Eryılmaz, Eser Lay Ergün, Alper Gürlek","doi":"10.1007/s00508-026-02821-w","DOIUrl":"https://doi.org/10.1007/s00508-026-02821-w","url":null,"abstract":"<p><p>Tumor-induced osteomalacia is a rare acquired disorder of phosphate metabolism caused by fibroblast growth factor (FGF)23-secreting mesenchymal tumors. We report the case of a 39-year-old man with a 3-year history of progressive musculoskeletal pain, in whom unrecognized hypophosphatemia led to misdiagnoses, including osteoporosis and inflammatory musculoskeletal disorders, and consequently, to inappropriate management. Biochemical evaluation revealed persistent hypophosphatemia, elevated alkaline phosphatase levels, secondary hyperparathyroidism, and markedly increased serum FGF23 levels. Gallium-68 DOTATATE positron emission tomography/computed tomography (PET/CT) identified a phosphaturic mesenchymal tumor located in the medial condyle of the right distal femur, which was subsequently confirmed histopathologically after surgical excision. Following surgery, serum phosphorus and FGF23 levels rapidly normalized, accompanied by significant clinical improvement. This case highlights unrecognized hypophosphatemia as a critical yet preventable cause of diagnostic delay and emphasizes the importance of routine serum phosphate assessment to avoid misdiagnosis and enable timely curative treatment.</p>","PeriodicalId":23861,"journal":{"name":"Wiener Klinische Wochenschrift","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149026178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Second victim experiences among Austrian nonphysician emergency medical services personnel : A cross-sectional analysis of symptom burden and associated factors. 奥地利非医师紧急医疗服务人员的第二次受害者经历:症状负担和相关因素的横断面分析。
IF 2.6 4区 医学
Wiener Klinische Wochenschrift Pub Date : 2026-09-21 DOI: 10.1007/s00508-026-02819-4
Katharina Tscherny, Victoria Klemm, Herbert Huscsava, Stefan Dür, Eva Potura, Reinhard Strametz
{"title":"Second victim experiences among Austrian nonphysician emergency medical services personnel : A cross-sectional analysis of symptom burden and associated factors.","authors":"Katharina Tscherny, Victoria Klemm, Herbert Huscsava, Stefan Dür, Eva Potura, Reinhard Strametz","doi":"10.1007/s00508-026-02819-4","DOIUrl":"https://doi.org/10.1007/s00508-026-02819-4","url":null,"abstract":"<p><strong>Background: </strong>Second victim experiences have been described across health professions but evidence for Austrian prehospital emergency medical services (EMS) remains limited. This study assessed the prevalence, key events and factors associated with high symptom burden among Austrian nonphysician emergency medical services personnel.</p><p><strong>Methods: </strong>We conducted a cross-sectional study within the Second Victims in German-speaking Countries (SeViD) research program using the standardized SeViD questionnaire among Austrian nonphysician EMS personnel. The SeViD-A4 denotes the fourth Austrian study within this program and does not refer to a separate questionnaire. Second victim status was recorded dichotomously and symptom burden was dichotomized for univariate analyses and multivariable binary logistic regression. The questionnaire included demographic and occupational variables, second victim experience, key event category, support after the key event, recovery, symptom reactions, support preferences and 10-item Big Five Inventory (BFI-10) personality dimensions.</p><p><strong>Results: </strong>A total of 1171 questionnaires were included and 60.1% of the respondents identified as second victims. Among participants with a second victim experience and valid key event data (n = 704), the most common key events were unexpected patient death or patient suicide (41.8%) and aggression by patients or relatives (18.8%). The multivariable complete case analysis included 698 participants, of whom 336 had high symptom burden. High symptom burden was associated with neuroticism (odds ratio, OR 1.44), openness (OR 1.21), patient volume per 100 additional patients per quarter (OR 1.14), professional compared with volunteer EMS work (OR 1.52), and lack of support despite seeking help (OR 5.98). Self-reported male gender was associated with lower odds of high symptom burden (OR 0.62).</p><p><strong>Conclusion: </strong>Second victim experiences were frequent in this nationwide Austrian convenience sample. High symptom burden was associated with individual, workload-related, employment-related and support-related factors. Low-threshold peer support and structured follow-up represent plausible organizational targets but their effectiveness requires prospective evaluation.</p>","PeriodicalId":23861,"journal":{"name":"Wiener Klinische Wochenschrift","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-09-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149012430","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Healthy rural living: a misplaced optimism? : District-level agricultural index and Parkinson's disease risk in Austria. 健康的农村生活:一种错位的乐观?奥地利地区级农业指数和帕金森病风险。
IF 2.6 4区 医学
Wiener Klinische Wochenschrift Pub Date : 2026-09-21 DOI: 10.1007/s00508-026-02817-6
A Santer, G Fülöp, A Langer, M Ludwig, H Cetin, F Zimprich, C Brücke, H Zach
{"title":"Healthy rural living: a misplaced optimism? : District-level agricultural index and Parkinson's disease risk in Austria.","authors":"A Santer, G Fülöp, A Langer, M Ludwig, H Cetin, F Zimprich, C Brücke, H Zach","doi":"10.1007/s00508-026-02817-6","DOIUrl":"https://doi.org/10.1007/s00508-026-02817-6","url":null,"abstract":"<p><strong>Background: </strong>Occupational exposure to pesticides is a well-established environmental risk factor for Parkinson's disease (PD). Living in agricultural regions has also been associated with PD risk, although evidence remains inconsistent. This study examines whether past district-level agricultural intensity is associated with current Parkinson's disease hospitalization prevalence across Austrian districts.</p><p><strong>Methods: </strong>We obtained district-level hospitalization prevalence data for individuals with a main or secondary diagnosis of PD from the Austrian national hospital discharge register for the years 2015-2023. Agricultural employment is quantified using an Agricultural Index (ACI), defined as the proportion of the working population employed in agriculture and forestry, derived from national population censuses conducted in 1981, 1991, and 2001. Associations between the cumulative ACI and cumulative PD hospitalization prevalence per region among the general population are assessed using Pearson correlation and linear regression analyses.</p><p><strong>Results: </strong>The cumulative ACI from 1981, 1991, and 2001 is significantly associated with PD hospitalization prevalence between 2015 and 2023 at the district level. In linear regression analysis, the cumulative ACI significantly predicts PD hospitalization prevalence (p = 0.01), explaining 6.8% of the variance (R<sup>2</sup> = 0.068).</p><p><strong>Conclusion: </strong>Austrian districts with historically higher agricultural employment and intensity exhibit higher contemporary hospitalization prevalences among individuals with Parkinson's disease (PD). These findings support existing evidence linking rural environments to increased PD risk and suggest that agricultural environmental exposures can affect not only agricultural workers but also the general population residing in highly agricultural regions.</p>","PeriodicalId":23861,"journal":{"name":"Wiener Klinische Wochenschrift","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-09-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149012355","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书